GLP-1 boom in China, India, Brazil could create $22 billion market by 2035, J.P. Morgan says
J.P. Morgan projects that the emerging market demand for GLP-1 medications in China, India, and Brazil will generate a $22 billion opportunity by 2035. This forecast highlights a significant shift in global pharmaceutical consumption patterns, moving beyond established Western markets. The report suggests that rapid growth in these regions will drive substantial revenue potential for drug manufacturers and distributors. Professionals should note this expansion as a key indicator of shifting healthcare priorities and commercial opportunities in emerging economies, reflecting broader trends in global health expenditure and accessibility.
The story
in brief.
What happened, who it affects, and why it landed on our intelligence desk — in plain English, sixty seconds or less.
J.P. Morgan projects that the emerging market demand for GLP-1 medications in China, India, and Brazil will generate a $22 billion opportunity by 2035. This forecast highlights a significant shift in global pharmaceutical consumption patterns, moving beyond established Western markets. The report suggests that rapid growth in these regions will drive substantial revenue potential for drug manufacturers and distributors. Professionals should note this expansion as a key indicator of shifting healthcare priorities and commercial opportunities in emerging economies, reflecting broader trends in global health expenditure and accessibility.
Indicative index of skill mentions in professional job postings for the field this story moves (2019 = 1)
What this means
for your career.
Every headline redistributes opportunity. Here is who this one rewards — and how to be on the right side of it.
This surge signals a critical pivot in global healthcare strategy, demanding professionals who can navigate complex emerging markets. You must prioritise skills in cross-cultural market entry and regulatory compliance, as localisation will dictate success. Roles in supply chain logistics and regional sales will see heightened demand to manage distribution networks efficiently. If you are in pharma or healthcare management, you should deepen your expertise in international regulatory frameworks and local partnership strategies. Consider upskilling in data analytics to interpret regional health trends accurately. Proactively engage with colleagues in these territories to understand on-the-ground challenges. This is not merely a sales opportunity but a strategic imperative requiring nuanced cultural and operational intelligence to capture this growing market share effectively.
For this story, the fields that convert it into pay are Healthcare Management, Supply Chain, Compliance And Governance and AI in Pharmaceuticals — exactly the programmes matched below. The chart shows the indicative salary uplift certified professionals report in each of those fields; every one of them is a click away, from £79, finishing in as few as 20 days.
Indicative ranges from published continuing-education salary studies, by field — each field is a recommended course below
Enrol in these
to benefit.
These programmes position you for exactly this shift — online, self-paced, and finishing with a verifiable certificate you can share the day you pass.
Best match
Certificate in Healthcare Management
Recommended
Certificate in Supply Chain
Recommended
Certificate in Compliance And Governance
Recommended
Certificate in AI in Pharmaceuticals
Launch pricing shown against standard certificate value. The fee you see today is the fee you lock in.
This briefing is based on reporting by Yahoo! Finance Canada on 23 Oct, 09:59. Read the original coverage →
Read the news. Then outrun it.
Every OnlineUni programme is online, self-paced and from £79 — so a headline today can be your credential this month.